Marianna Silletta

Marianna Silletta

Università Campus Bio Medico di Roma - Rome / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1800503
Campus Bio-Medico University of Rome
person_outline Marianna Silletta's MOST POPULAR ARTICLES
1-) The biological properties of cetuximabB Vincenzi, G Schiavon, M Silletta, D Santini, G ToniniCritical reviews in oncology/hematology 68 (2), 93-106, 20081612008
2-) Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: a …B Vincenzi, M Di Maio, M Silletta, L D’Onofrio, C Spoto, MC Piccirillo, ...PloS one 10 (7), e0133488, 20151182015
3-) Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, V Burgio, S Shigeo, T Tada, G Suda, ...ESMO open 7 (6), 100591, 2022702022
4-) Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide populationA Casadei-Gardini, M Rimini, T Tada, G Suda, S Shimose, M Kudo, ...European Journal of Cancer 180, 9-20, 2023922023
5-) Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcomeB Vincenzi, D Santini, S Galluzzo, A Russo, F Fulfaro, M Silletta, ...Clinical cancer research 14 (13), 4219-4224, 2008692008